SPRAVATO®
SPRAVATO® Treatment Now Available at Diley Medical Group
Diley Medical Group is now a REMS‑certified SPRAVATO® (esketamine) Treatment Center, offering this FDA‑approved option for adults with treatment‑resistant depression under the required monitoring and safety protocols.
What Is SPRAVATO®?
SPRAVATO® (esketamine) is a prescription nasal spray used along with an oral antidepressant for adults with treatment‑resistant depression. Because of important safety requirements, it can only be administered in a REMS‑certified medical setting where patients are monitored during and after treatment.
Why Diley Medical Group Now Offers SPRAVATO®
As a privately owned, patient‑driven practice, we are committed to expanding access to evidence‑based mental health treatments. Adding SPRAVATO® allows us to support patients who have tried two or more antidepressants without adequate relief and may need a different approach.
Our team provides:
- A safe, comfortable treatment environment
- Monitoring before, during, and after each session
- Coordination with your referring provider
- Support throughout your treatment journey
What to Expect During Treatment
Because SPRAVATO® must be taken in‑office, patients remain at the clinic for observation after each dose. Our care team guides you through every step, from your first appointment to ongoing follow‑up.
Patients may also access educational materials such as the SPRAVATO® Patient Video Gallery and in‑office brochures to better understand the treatment process.
How to Get Started
If you believe SPRAVATO® may be right for you, or if you are a provider interested in referring a patient, please contact our office. We will walk you through eligibility, scheduling, and next steps.
